跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Foster Pressurised Inhalation Solution 200mcg/6mcg per Actuation - HSA Drug Approval Details
Approvals
/
HSA
/
Foster Pressurised Inhalation Solution 200mcg/6mcg per Actuation
Approved
THERAPEUTIC
Foster Pressurised Inhalation Solution 200mcg/6mcg per Actuation
Chiesi Farmaceutici S.p.A.
🇸🇬 Health Sciences Authority
Approval Date
Sep 25, 2024
Approval ID
e12e07416f0f8954
Company
Chiesi Farmaceutici S.p.A.
Type
Therapeutic
Approval Details
Approval Id
e12e07416f0f8954
Drug Name
Foster Pressurised Inhalation Solution 200mcg/6mcg per Actuation
Product Name
Foster Pressurised Inhalation Solution 200mcg/6mcg per Actuation
Approval Number
SIN17100P
Approval Date
2024-09-25
Registrant
ORIENT EUROPHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
AEROSOL, METERED
Route Of Administration
RESPIRATORY (INHALATION)
Atc Code
R03AK08
Pharma Manufacturer Name
ORIENT EUROPHARMA PTE LTD
Company Detail Path
/organization/orient-europharma-pte-ltd
Active Ingredients
Beclometasone dipropionate
0.200mg/actuation
Formoterol fumarate dihydrate
0.006mg/actuation
Beclometasone dipropionate
0.200mg/actuation
Formoterol fumarate dihydrate
0.006mg/actuation
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 25, 2024
Approval ID
e12e07416f0f8954
Type
Therapeutic
Back to HSA Approvals
